Resultat från LIFE-studien: Lovande effekter av en ny klass hypertoniläkemedel
(2002) In Läkartidningen 99(16). p.4-1792
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/115286
- author
- Nilsson, Peter LU and Kahan, Thomas
- organization
- alternative title
- Results from the LIFE study: promising effects of new hypertensive agents
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Angiotensin II: antagonists & inhibitors, Randomized Controlled Trials, Human, Comparative Study, Atenolol: therapeutic use, Antihypertensive Agents: therapeutic use, Hypertension: complications, Hypertension: drug therapy, Left Ventricular: drug therapy, Hypertrophy, Middle Age, Losartan: therapeutic use, Adult, Adrenergic beta-Antagonists: therapeutic use, Left Ventricular: complications, Treatment Outcome
- in
- Läkartidningen
- volume
- 99
- issue
- 16
- pages
- 4 - 1792
- publisher
- Swedish Medical Association
- external identifiers
-
- pmid:12043477
- scopus:0037129036
- ISSN
- 0023-7205
- language
- Swedish
- LU publication?
- yes
- id
- d5fb765a-880b-48e0-a529-7c32f47dbc5c (old id 115286)
- alternative location
- http://ltarkiv.lakartidningen.se/artNo24632
- date added to LUP
- 2016-04-01 16:58:13
- date last changed
- 2022-04-15 08:15:20
@article{d5fb765a-880b-48e0-a529-7c32f47dbc5c, author = {{Nilsson, Peter and Kahan, Thomas}}, issn = {{0023-7205}}, keywords = {{Angiotensin II: antagonists & inhibitors; Randomized Controlled Trials; Human; Comparative Study; Atenolol: therapeutic use; Antihypertensive Agents: therapeutic use; Hypertension: complications; Hypertension: drug therapy; Left Ventricular: drug therapy; Hypertrophy; Middle Age; Losartan: therapeutic use; Adult; Adrenergic beta-Antagonists: therapeutic use; Left Ventricular: complications; Treatment Outcome}}, language = {{swe}}, number = {{16}}, pages = {{4--1792}}, publisher = {{Swedish Medical Association}}, series = {{Läkartidningen}}, title = {{Resultat från LIFE-studien: Lovande effekter av en ny klass hypertoniläkemedel}}, url = {{http://ltarkiv.lakartidningen.se/artNo24632}}, volume = {{99}}, year = {{2002}}, }